PMA device
OPTIMIZER Smart System
Impulse Dynamics (Usa), Inc. · Implantable Pulse Generator (QFV, Class III) · First FDA decision Mar 21, 2019, newest Jul 15, 2025Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
11
PMA pathway
Device trials
8
Naming "OPTIMIZER Smart"
MAUDE reports
167
Brand "OPTIMIZER Smart", since 2015
PubMed studies
14
Mentioning "OPTIMIZER Smart"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OPTIMIZER Smart System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 11 decisions filed under this name.
- OPTIMIZER Smart SystemPMA supplement
P180036-S038 · Decided Jul 15, 2025 · 146 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable pulse generator (QFV) · Cardiology
5 more FDA decisions with a free account
Older decisions: P180036-S008, P180036-S006, P180036-S005, P180036-S003, P180036
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OPTIMIZER Smart", any status and sponsor, newest update first.
- Assessment of CCM in HF With Higher Ejection FractionPivotal-lookingRecruiting
Impulse DynamicsNot on our public-company list
NCT05064709 · 1,500 participants (planned) · Start Feb 3, 2022 · Primary completion Feb 1, 2029
Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System; OPTIMIZER™ Smart Mini System · For: Heart Failure; Heart Failure With Preserved Ejection Fraction; Heart Failure With Mid Range Ejection Fraction and 2 more
Sites: Birmingham, Alabama; Mesa, Arizona; Scottsdale, Arizona · 67 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OPTIMIZER Smart", and for the whole product code for context.
This brand
167 reports: 56 malfunction, 108 injury, 3 death
Whole product code QFV
183 reports: 61 malfunction, 119 injury, 3 death
Newest reports for this brand
- OPTIMIZER Smart MiniInjury
3012563838-2026-00080 · Received Oct 28, 2026 · Event dated Sep 28, 2026
Device type: Implantable Pulse Generator (QFV)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OPTIMIZER Smart"[tiab]. The summary above synthesizes these.
- [Not Available].
Uskach TM, Tereshchenko SN, Pavlenko TA, et al. · Kardiologiia · 2019
- Optimizer Smart in the treatment of moderate-to-severe chronic heart failure.
Campbell CM, Kahwash R, Abraham WT · Future Cardiol · 2020Review
- Streamlining Randomized Clinical Trials for Device Therapies in Heart Failure: Bayesian Borrowing of External Data.
Saville BR, Burkhoff D, Abraham WT · J Am Heart Assoc · 2024
- Optimizer Smart System for the treatment of chronic heart failure: Overview of its safety and efficacy.
Chera HH, Al-Sadawi M, Michelakis N, et al. · Expert Rev Med Devices · 2021Review
- Cardiac contractility modulation for the treatment of moderate to severe HF.
Rao IV, Burkhoff D · Expert Rev Med Devices · 2021Review
- "Optimizing" the Anesthetic for Cardiac Contractility Modulation Devices.
Ghia S, Allen A, Suri R, et al. · J Innov Card Rhythm Manag · 2025Case Reports
- Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study.
Masarone D, Kittleson MM, De Vivo S, et al. · J Clin Med · 2022
- A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS.
Visco V, Esposito C, Manzo M, et al. · Front Cardiovasc Med · 2022Case Reports
- The Effects of Device-Based Cardiac Contractility Modulation Therapy on Left Ventricle Global Longitudinal Strain and Myocardial Mechano-Energetic Efficiency in Patients with Heart Failure with Reduced Ejection Fraction.
Masarone D, Kittleson MM, De Vivo S, et al. · J Clin Med · 2022
- New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment.
Tint D, Florea R, Micu S · J Clin Med · 2019
- Acute Hemodynamic Changes Induced by Cardiac Contractility Modulation Evaluated Using the NICaS® System: A Pilot Study.
Madeo A, De Bonis S, Cavaliere AL, et al. · J Clin Med · 2025
- Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system.
Kuschyk J, Falk P, Demming T, et al. · Eur J Heart Fail · 2021
Other devices of this type
Also filed under product code QFV.
- OPTIMIZER Smart Mini Implantable Pulse Generation (IPG)Impulse Dynamics (Usa), Inc. · PMA 2023
- OPTIMIZER Smart, OPTIMIZER Smart MiniImpulse Dynamics (Usa), Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.